Revolutionary patch technology platform
Our technology enables significant therapeutic improvements for patients, practitioners and societies all over the world
.button-55bb20938db15 { margin-bottom: 0px; margin-top: 0px; min-width: 0px !important; } .button-55bb20938db15 { background-color:#83c9c2; } .mk-button.button-55bb20938db15.flat-dimension:hover { background-color: !important; }
Cutting-edge research brings innovative power
Our technology stems from many years of research within the field of pharmacology, medicine, drug delivery systems, drug development and -design.
.button-55bb20938df3c { margin-bottom: 0px; margin-top: 0px; min-width: 0px !important; } .button-55bb20938df3c { background-color:#83c9c2; } .mk-button.button-55bb20938df3c.flat-dimension:hover { background-color: !important; }
#mk-edge-slider-55bb20938d019 { background-color: #83c9c2; }

Patch technology company

Swedish Pharma is a cutting-edge biotechnology company focusing on the development and commercialization of novel and advanced patch technologies. Our team consists of researchers with extensive experience within the field of medicine, pharmacology, novel patch technology, drug delivery systems-, development-, and design. Swedish Pharma was founded in 2007 and is currently situated in Stockholm, Sweden.

.full-width-55bb20938e402 { min-height:0px; padding:80px 0 80px; margin-bottom:0px; background-color:#ffffff; border:1px solid #ffffff;border-left:none;border-right:none; } #background-layer--55bb20938e402 { background-position:left top; background-repeat:repeat; ; } .full-width-55bb20938e402 .mk-fancy-title.pattern-style span, .full-width-55bb20938e402 .mk-blog-view-all { background-color: #ffffff !important; }

Technology platform

Trough many years of research our team has developed and patented a highly unique bioadhesive patch technology with significant potential in a wide array of therapeutic areas.

Technology capabilities

Three significant capabilities distinguishes our technology from that of any of our competitors – making it one of the most versatile patch technologies of today.

icon_adhesion_white_530px

SUPERIOUR
ADHESION

icon_drug_delivery_performance_white_530px

DRUG DELIVERY PERFORMANCE

icon_flexibility_white_530px

PRODUCT
FLEXIBILITY

.full-width-55bb20938ec11 { min-height:0px; padding:80px 0 80px; margin-bottom:0px; background-color:#666666; } #background-layer--55bb20938ec11 { background-image:url(http://swedishpharma.com/wp-content/uploads/Swedish-Pharma–lightgrey-polygons-background_2000px.png); background-position:left top; background-repeat:repeat; background-attachment: fixed;; } .mk-main-wrapper { display: none; } #theme-page { padding-top:0; } .full-width-55bb20938ec11 .mk-fancy-title.pattern-style span, .full-width-55bb20938ec11 .mk-blog-view-all { background-color: #666666 !important; }

Core application areas

Swedish Pharma utilizes the versatility in its patch technology to develop applications within two primary business areas.

.full-width-55bb209391360 { min-height:100px; padding:80px 0 50px; margin-bottom:0px; background-color:#ffffff; } #background-layer--55bb209391360 { background-position:left top; background-repeat:repeat; ; } .full-width-55bb209391360 .mk-fancy-title.pattern-style span, .full-width-55bb209391360 .mk-blog-view-all { background-color: #ffffff !important; }

icon_drug_delivery_530px

Drug delivery systems (DDS)

The world’s first patch technology that allows for topical, transdermal and transmucosal delivery of water-soluble pharmaceuticals in clinically relevant concentrations.

icon_wound_care_530px

Advanced wound care (AWC)

Firm adhesive effect to dry and wet skin, wounds, mucosa, genitals, nails and eyes. Shapes, attachment time and materials can be altered in accordance with customer-specific demands.

.full-width-55bb209391925 { min-height:100px; padding:10px 0 80px; margin-bottom:0px; } #background-layer--55bb209391925 { background-position:left top; background-repeat:repeat; ; }

Focus on drug delivery systems (DDS)

Our bioadhesive patch technology has successfully been used in clinical studies as a vehicle of 5ALA in photodynamic treatment (PDT) of superficial neoplastic lesions. PDT is an established and growing therapeutic methodology primarily applied in the treatment of mild to moderate actinic keratosis, a pre-cancerous affliction to the skin normally caused by excessive sun exposure. To find out more about our research results and how it could possibly reinvent the way we use PDT in non-melanoma skin cancer treatment – press here.

.full-width-55bb209392b69 { min-height:300px; padding:0px 0 0px; margin-bottom:0px; background-color:#f0f0f0; } #background-layer--55bb209392b69 { background-image:url(http://swedishpharma.com/wp-content/uploads/Swedish-Pharma-green-polygon_3000x1450px.png); background-position:left top; background-repeat:repeat; background-attachment: fixed;; } .full-width-55bb209392b69 .mk-fancy-title.pattern-style span, .full-width-55bb209392b69 .mk-blog-view-all { background-color: #f0f0f0 !important; }

Interested in our technology?

Swedish Pharma is always in search for promising strategic partnership agreements to improve the quality of our own project portfolio or contribute to others. We are interested in collaborating with academic and industrial actors in further vertical research and/or commercial projects. Our approach to different collaboration models is pragmatic and we invite open enquiries.

For further information, please contact us at:
adam.lindberg@swedishpharma.com or +46 (0) 725 38 71 22

#mk-tabs-55bb209395157 .mk-tabs-tabs li.ui-tabs-active a, #mk-tabs-55bb209395157 .mk-tabs-panes, #mk-tabs-55bb209395157 .mk-fancy-title span{ background-color: #ffffff; }
.full-width-55bb209394a78 { min-height:100px; padding:100px 0 80px; margin-bottom:0px; } #background-layer--55bb209394a78 { background-position:left top; background-repeat:repeat; ; }
Contact Us

Send us an email if you have any questions and we'll get back to you.